What's new

Human medicines European public assessment report (EPAR): Sugammadex Piramal, sugammadex, Date of authorisation: 23/06/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Sugammadex Piramal, sugammadex, Date of authorisation: 23/06/2023, Revision: 2, Status: Authorised

Apr 14, 2025 - 09:40
 0
Human medicines European public assessment report (EPAR): Sugammadex Piramal, sugammadex, Date of authorisation: 23/06/2023, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Sugammadex Piramal, sugammadex, Date of authorisation: 23/06/2023, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Novotel’s Momentum: Driving Growth Through Innovation, Impact and Sustainability

Next Article

Arab Fashion Council Launches $500,000 Designer Fund

Related Posts

Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Herbal medicinal product: Salviae officinalis foliumArray, C: ongoing call for scientific data

Herbal medicinal product: Salviae officinalis foliumArr...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025  0